Physician profile
Meredith Harris
NPI 1215322102
$2,700.03
in general payments reported to CMS, 2019-2025
8 companies · $47.28 in 2025
The $47.28 reported for 2025 was less than what a typical Pediatric Nephrology provider received nationally (typical 2025 total: $131).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $18.45 · 2021: $87.69 · 2023: $27.33 · 2024: $2,519 · 2025: $47.28.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,274 · Food and Beverage: $317 · Education: $2.55.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,274.00 |
| Food and Beverage | $317.34 |
| Education | $2.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $2,455.26 | 2024 | Rivfloza |
| Alexion Pharmaceuticals, INC. | $87.69 | 2021 | |
| Apellis Pharmaceuticals, INC. | $44.73 | 2025 | Empaveli |
| Novo Nordisk Health Care Ag | $44.52 | 2024 | |
| Travere Therapeutics, INC. | $29.88 | 2023-2025 | Thiola |
| Amgen INC. | $19.50 | 2024 | Procysbi |
| Covidien LP | $18.45 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Meredith Harris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.